MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1
- PMID: 30302807
- DOI: 10.1002/jcb.27822
MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1
Abstract
Osteosarcoma (OS) is considered the most common type of primary malignant bone tumor, which has a high rate of mortality in children and adolescents. However, the current treatment methods for OS are ineffective. Therefore, there is an urgent requirement to identify the critical targets. This study aimed to identify the roles and significance of microRNA-216b (miR-216b) in OS. To explore the cellular and molecular functions of miR-216b and Forkhead Box M1 (FoxM1) in OS, the expression of miR-216b and FoxM1 at the transcriptional level was measured using quantitative real-time PCR (qRT-PCR). Wound healing assay, 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide assay (MTT) assay, flow cytometry, and transwell invasion assay were conducted to study the function of miR-216b and FoxM1 in OS cells. Dual luciferase reporter assay was performed to identify the relationships between miR-216b and FoxM1. qRT-PCR results revealed that miR-216b expression was significantly downregulated, and FoxM1 was observed to be significantly upregulated in human OS cell lines (MG-63) and tissues. MTT data showed that upregulation of miR-216b expression led to cell growth inhibition in MG-63 cells. The results of the invasion assay and wound healing assay illustrated that miR-216b upregulation or FoxM1 downregulation could inhibit the invasion and migration in MG-63 cells. In vivo, the tumor volume was significantly decreased by miR-194 mimic treatment compared with the control group. Furthermore, the results of the luciferase assay indicated that FoxM1 is a direct target of miR-216b. These findings may provide novel insights into the molecular mechanism of miR-216b and FoxM1 in the progression of OS, and suggested that miR-216b may serve as a potential tumor inhibitor of OS by targeting FoxM1.
Keywords: Forkhead Box M1 (FoxM1); cell invasion; cell migration; cell proliferation; microRNA-216b (miR-216b); osteosarcoma (OS).
© 2018 Wiley Periodicals, Inc.
Similar articles
-
LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.J Cell Physiol. 2019 Aug;234(8):13464-13480. doi: 10.1002/jcp.28026. Epub 2019 Jan 9. J Cell Physiol. 2019. PMID: 30624782
-
miR-216b inhibits glioma cell migration and invasion through suppression of FoxM1.Oncol Rep. 2017 Sep;38(3):1751-1759. doi: 10.3892/or.2017.5824. Epub 2017 Jul 17. Oncol Rep. 2017. Retraction in: Oncol Rep. 2024 Jan;51(1):4. doi: 10.3892/or.2023.8663. PMID: 28731180 Retracted.
-
microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.Cell Biol Int. 2017 Dec;41(12):1272-1282. doi: 10.1002/cbin.10754. Epub 2017 Sep 10. Cell Biol Int. 2017. PMID: 28225180
-
MicroRNA-143 expression inhibits the growth and the invasion of osteosarcoma.J Orthop Surg Res. 2022 Apr 13;17(1):236. doi: 10.1186/s13018-022-03127-z. J Orthop Surg Res. 2022. PMID: 35418302 Free PMC article. Review.
-
Therapeutic targeting of miRNA-216b in cancer.Cancer Lett. 2020 Aug 1;484:16-28. doi: 10.1016/j.canlet.2020.04.020. Epub 2020 May 5. Cancer Lett. 2020. PMID: 32387443 Review.
Cited by
-
Identification of m7G Methylation-Related miRNA Signature Associated with Survival and Immune Microenvironment Regulation in Uterine Corpus Endometrial Carcinoma.Biomed Res Int. 2022 Nov 23;2022:8776678. doi: 10.1155/2022/8776678. eCollection 2022. Biomed Res Int. 2022. PMID: 36467881 Free PMC article.
-
Differential Expression of miRNAs in Hypoxia ("HypoxamiRs") in Three Canine High-Grade Glioma Cell Lines.Front Vet Sci. 2020 Feb 28;7:104. doi: 10.3389/fvets.2020.00104. eCollection 2020. Front Vet Sci. 2020. PMID: 32258065 Free PMC article.
-
Comprehensive bioinformatics analysis reveals the oncogenic role of FoxM1 and its impact on prognosis, immune microenvironment, and drug sensitivity in osteosarcoma.J Appl Genet. 2023 Dec;64(4):779-796. doi: 10.1007/s13353-023-00785-5. Epub 2023 Oct 2. J Appl Genet. 2023. PMID: 37782449
-
microRNA-758 inhibits the malignant phenotype of osteosarcoma cells by directly targeting HMGA1 and deactivating the Wnt/β-catenin pathway.Am J Cancer Res. 2019 Jan 1;9(1):36-52. eCollection 2019. Am J Cancer Res. 2019. PMID: 30755810 Free PMC article.
-
FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion.Cancer Manag Res. 2020 Oct 9;12:9857-9867. doi: 10.2147/CMAR.S270825. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116844 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous